A cholesterol/lipid profile screening project of high risk patients with hyperlipidaemia (secondary prevention) who already receive cholesterol-lowering therapy. Lipid profile and rate of patients who are treated to target (which is \<100mg/dl for patients with high risk and \<70mg/dl for patients at very high risk) are screened (hospital-based specialists). The doctors therapy decisions after the screening and possible reasons for these decisions will be documented. Our aim is to evaluate dosing habits, to evaluate how many patients are treated to their LDL-C target and to underline the importance of treating patients to their cholesterol targets.
Study Type
OBSERVATIONAL
Enrollment
1,096
Research Site
Rohrbach, Upper Austria, Austria
Cholesterol levels
Cholesterol levels from high risk patients after 4 weeks of cholesterol-lowering drug therapy under target values
Time frame: After 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.